serw-MX  [xml]  
 


    
 DeCS Categories

D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.472 Hormones .
D06.472.334 Gonadal Hormones .
D06.472.334.984 Testicular Hormones .
D06.472.334.984.500 Anti-Mullerian Hormone .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.875 Reproductive Control Agents .
D27.505.696.875.360 Contraceptive Agents .
D27.505.954 Therapeutic Uses .
D27.505.954.122 Anti-Infective Agents .
D27.505.954.122.085 Anti-Bacterial Agents .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.106 Antibiotics, Antineoplastic .
D27.505.954.705 Reproductive Control Agents .
D27.505.954.705.360 Contraceptive Agents .
D27.888 Toxic Actions .
D27.888.569 Noxae .
D27.888.569.199 Cytostatic Agents .
E02 Therapeutics .
E02.183 Clinical Protocols .
E02.183.750 Antineoplastic Protocols .
E02.319 Drug Therapy .
E02.319.077 Antineoplastic Protocols .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.775 Epidemiologic Study Characteristics .
N05.715.360.775.225 Clinical Protocols .
N05.715.360.775.225.500 Antineoplastic Protocols .
SP4 Environmental Health .
SP4.001 Health .
SP4.001.022 Pest Control .
SP4.001.022.238 Pesticides .
SP4.001.022.238.359 Anti-Bacterial Agents .
SP4.011 Science .
SP4.011.102 Biology .
SP4.011.102.088 Anti-Bacterial Agents .
VS2 Health Surveillance of Products .
VS2.002 Drug and Narcotic Control .
VS2.002.001 Pharmaceutical Preparations .
VS2.002.001.012 Anti-Bacterial Agents .
VS2.004 Control and Sanitary Supervision of Sanitizing Products .
VS2.004.001 Sanitizing Products .
VS2.004.001.002 Products with Antimicrobial Action .
VS2.004.001.002.006 Anti-Bacterial Agents .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Antineoplastic Agents .
Anticancer Agents .
Antineoplastic Drugs .
Antineoplastics .
Antitumor Agents .
Antitumor Drugs .
Cancer Chemotherapy Agents .
Cancer Chemotherapy Drugs .
Chemotherapeutic Anticancer Agents .
Chemotherapeutic Anticancer Drug .
Agents, Anticancer .
Agents, Antineoplastic .
Agents, Antitumor .
Agents, Cancer Chemotherapy .
Agents, Chemotherapeutic Anticancer .
Chemotherapy Agents, Cancer .
Chemotherapy Drugs, Cancer .
Drug, Chemotherapeutic Anticancer .
Drugs, Antineoplastic .
Drugs, Antitumor .
Drugs, Cancer Chemotherapy .
Antineoplastic and Immunosuppressive Agents .
Antineoplastics, Immunosuppressives .
Substances that inhibit or prevent the proliferation of NEOPLASMS. .
1.00
 
Cytostatic Agents .
Cytostatic Drugs .
Cytostatics .
Compounds that inhibit or prevent the proliferation of CELLS. .
0.66
 
Antibiotics, Antineoplastic .
Antibiotics, Cytotoxic .
Cytotoxic Antibiotics .
Antineoplastic Antibiotics .
Antibiotics, Anthracycline .
Anthracycline Antibiotics .
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. .
0.58
 
Anti-Bacterial Agents .
Anti-Bacterial Compounds .
Anti-Mycobacterial Agents .
Antibacterial Agents .
Antibiotic .
Antimycobacterial Agents .
Bacteriocidal Agents .
Bacteriocides .
Agents, Anti-Bacterial .
Agents, Anti-Mycobacterial .
Agents, Antibacterial .
Agents, Antimycobacterial .
Agents, Bacteriocidal .
Anti Bacterial Agents .
Anti Bacterial Compounds .
Anti Mycobacterial Agents .
Compounds, Anti-Bacterial .
Antibiotics .
Antibiotic Drugs .
Antibiotics, Peptide .
Peptide Antibiotics .
Antibiotics, Glycopeptide .
Antibiotics, Macrolide .
Macrolide Antibiotics .
Antibiotics, Aminoglycoside .
Aminoglycoside Antibiotics .
Antibiotics, Glycoside .
Glycoside Antibiotics .
Substances that inhibit the growth or reproduction of BACTERIA. .
0.52
 
Contraceptive Agents .
Contraceptive Effect .
Contraceptive Effects .
Contraceptives .
Agents, Contraceptive .
Effect, Contraceptive .
Effects, Contraceptive .
Chemical substances that prevent or reduce the probability of CONCEPTION. .
0.51
 
Antineoplastic Protocols .
Antineoplastic Protocol .
Cancer Treatment Protocol .
Protocol, Antineoplastic .
Protocol, Cancer Treatment .
Protocols, Antineoplastic .
Protocols, Cancer Treatment .
Treatment Protocol, Cancer .
Treatment Protocols, Cancer .
Cancer Treatment Protocols .
Clinical protocols used to inhibit the growth or spread of NEOPLASMS. .
0.45
 
Reproductive Control Agents .
Agents, Reproductive Control .
Control Agents, Reproductive .
Substances used either in the prevention or facilitation of pregnancy. .
0.43
 
Anti-Mullerian Hormone .
Anti-Mullerian Factor .
Antimullerian Hormone .
Mullerian Inhibiting Hormone .
Mullerian Inhibiting Substance .
Mullerian Regression Factor .
Mullerian-Inhibiting Factor .
Mullerian-Inhibitory Substance .
Anti Mullerian Factor .
Anti Mullerian Hormone .
Mullerian Inhibiting Factor .
Mullerian Inhibitory Substance .
Mullerian-Inhibiting Hormone .
A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM. .
0.39